News

Gladstone in the News April 27, 2020

COVID-19 Immunity: The Great Unknown

MEDPAGE Today—It’s not yet known if the presence of antibodies to SARS-CoV-2, the virus that causes COVID-19, will confer a lasting immunity to the disease. Gladstone Senior Investigator Warner Greene explains that people who had been infected with the related SARS virus showed immunity for up to 6 years, providing some hope that a similar response may protect individuals from repeated COVID-19 infections.

Gladstone Experts COVID-19 Infectious Disease Greene Lab

Gladstone in the News April 25, 2020

Kaiser Study Finds Coronavirus Seriously Affects People Regardless of Age

San Francisco Chronicle—New research in California shows that young and middle-aged adults may be as vulnerable to COVID-19 as senior citizens are. Gladstone Senior Investigator Warner Greene explains that this finding differs from earlier studies in Italy and China.

Gladstone Experts COVID-19 Greene Lab

Gladstone in the News April 24, 2020

Bay Area Medical Expert Warns Dangers of Injecting Disinfectants after Trump Suggests to Do So

KRON4—Gladstone Senior Investigator Warner Greene explains that the scientific community is hard at work trying to identify therapies to treat COVID-19, and warns that disinfectants are poisonous and should not be ingested.

Gladstone Experts COVID-19 Infectious Disease Greene Lab

Article April 24, 2020

From HIV to COVID-19

Researchers who spent decades studying human immunodeficiency virus are using some of the same tools and approaches to tackle SARS-CoV-2, the virus that causes COVID-19.

Gladstone Experts COVID-19 HIV/AIDS Center for HIV Cure Research Infectious Disease Akassoglou Lab Doudna Lab Greene Lab Ott Lab

Article April 22, 2020

Data-Driven Discovery

Many Gladstone researchers rely on computational approaches, machine learning, and innovative software to make biomedical discoveries.

Gladstone Experts Bioinformatics Core HIV/AIDS Zika Virus Center for HIV Cure Research Center for Systems and Therapeutics Data Science and Biotechnology Neurological Disease Infectious Disease Finkbeiner Lab

Video April 20, 2020

SARS-CoV-2 and the COVID-19 Pandemic

Warner Greene, MD, PhD, brings his expertise in the field of virology to share insight on SARS-CoV-2 and the COVID-19 pandemic.

Gladstone Experts COVID-19 Greene Lab

Gladstone in the News April 20, 2020

“Crushed the Curve”—Researcher Says Steps Taken in California Have Done More than Flatten the Curve

KRON4—Gladstone virologist Warner Greene explains that the shelter in place order has helped California control the spread of COVID-19, but warns that individuals must continue to be vigilant and practice social distancing to protect against a resurgence.

Gladstone Experts COVID-19 Infectious Disease Greene Lab

Gladstone in the News April 20, 2020

Hundreds of Thousands in LA County May Have Been Infected with Coronavirus, Study Finds

Los Angeles Times—A study in Los Angeles county suggests that the number of COVID-19 cases may be much higher than originally thought, because many people experienced mild symptoms. Gladstone Investigator Warner Greene explains that scientists agree that many cases have been missed, but remain unsure of the true number.

Gladstone Experts COVID-19 Infectious Disease Greene Lab

Gladstone in the News April 19, 2020

Nobel Laureate Yamanaka Frets over Japan’s Lax Coronavirus Fight

Nikkei Asian Review—Gladstone Senior Investigator Shinya Yamanaka is concerned about the spread of COVID-19 in Japan. To help keep people informed, he has begun a blog to share his scientific insights about the importance of social distancing and to shed light on how scientists are working to fight the virus.

Gladstone Experts COVID-19 Yamanaka Lab

Gladstone in the News April 19, 2020

What We Know, and Don’t Know, a Month into Bay Area’s Shelter-in-Place Order

San Francisco Chronicle—Senior Investigator Warner Greene describes how quick action to close businesses and send people home helped the Bay Area “crush the curve” of COVID-19.

Gladstone Experts COVID-19 Infectious Disease Greene Lab

Gladstone in the News April 17, 2020

The Promise and Peril of Antibody Testing for COVID-19

JAMA Network—Antibody tests could help identify who has already been infected with SARS-CoV-2, and may now be immune. Gladstone Investigator Melanie Ott explains that understanding how far immunity has spread could help determine when it will be safe to ease social distancing requirements.

Gladstone Experts COVID-19 Infectious Disease Ott Lab

Article April 15, 2020

ChemPartner and Gladstone Institutes Announce COVID-19 Research Collaboration

Leading contract research and development organization partners with world-class virology team to fight the COVID-19 pandemic

COVID-19 Infectious Disease

Gladstone in the News April 14, 2020

To Accelerate Innovation, the CDC Should Ease Limits on Which Labs Can Handle the Coronavirus

STAT News—The Centers for Disease Control and Prevention currently requires that research on SARS-CoV-2, the virus that causes COVID-19, be conducted in special biosafety level 3 labs (BSL-3). Senior Investigator Melanie Ott explains why that requirement could slow down research progress.

Gladstone Experts COVID-19 Ott Lab

Article April 13, 2020

Toxic Cell Atlas Guides New Therapies for Neurodegeneration

New study generates an “atlas” of toxic immune cells in the brain.

News Release Research (Publication) Assay Development and Drug Discovery Core Neurological Disease Akassoglou Lab

Gladstone in the News April 13, 2020

Coronavirus: How Is San Francisco Testing at Nearly Double the Rate of LA?

Mercury News—San Francisco has the highest per capita COVID-19 testing rate in California. Senior Investigator Warner Greene helps explain why widespread testing is so important to getting the outbreak under control.

Gladstone Experts COVID-19 Infectious Disease Greene Lab